Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KGC vs GSK✓SelectedUSD · GSKKGC vs GSK performance historyLatest closeAs of-5.81%11/18
Stock and ETF performance explorer

KGC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+202.9%
GSK return
+42.7%
Excess return
+160.2%
Maximum drawdown
-53.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.8%-1.3%-4.5%-5.5%
7D-11.6%-3.1%-8.5%-10.9%
30D-19.8%-0.9%-18.9%-19.7%
3M-30.0%-4.2%-25.8%-29.2%
6M-33.3%-1.6%-31.7%-33.2%
YTD-32.4%+2.6%-35.0%-32.9%
1Y-24.9%+6.2%-31.1%-26.2%
3Y+267.8%+55.0%+212.8%+208.2%
5Y+202.9%+42.8%+160.0%+152.9%
All+202.9%+42.7%+160.2%+152.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling